AWM
NKTR icon

Activest Wealth Management’s Nektar Therapeutics NKTR Stock Holding History

Activest Wealth Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14K Hold
200
– – ﹤0.01% 514
2026
Q1 		$14.4K Hold
200
– – ﹤0.01% 603
2025
Q4 		$8.46K Hold
200
– – ﹤0.01% 691
2025
Q3 		$11.4K Hold
200
– – ﹤0.01% 478
2025
Q2 		$5.17K Hold
200
– – ﹤0.01% 544
2025
Q1 		$2.04K Hold
200
– – ﹤0.01% 656
2024
Q4 		$2.79K Hold
200
– – ﹤0.01% 412
2024
Q3 		$3.9K Hold
200
– – ﹤0.01% 384
2024
Q2 		$3.72K Buy
+200
New +$4.21K ﹤0.01% 364

Other funds holding NKTR

MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
G
Gainplan Bloomfield Hills, Michigan $254M AUM 25.62% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
LA
LVW Advisors Pittsford, New York $1.16B AUM 26.37% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return

Activest Wealth Management's NKTR Position: Q2 2026 in Review

Activest Wealth Management held its Nektar Therapeutics (NKTR) position steady in Q2 2026 at 200 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #514.

Activest Wealth Management first reported a position in NKTR in Q2 2024 and has held it in 9 quarters since. The position peaked at $14.4K in Q1 2026. 11 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Activest Wealth Management held 200 shares of Nektar Therapeutics worth $14K as of Q2 2026.
  • Activest Wealth Management left its Nektar Therapeutics share count unchanged in Q2 2026.
  • Nektar Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #514 holding.
  • Activest Wealth Management first reported a position in Nektar Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Activest Wealth Management's Nektar Therapeutics position peaked at $14.4K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.